Nidanilimab (Anti-IL-1RAP / IL-1R3)

Ask the supplier | View on supplier's website

Nidanilimab (Anti-IL-1RAP / IL-1R3) is a fully humanized monoclonal antibody targeting IL1RAP and blocks IL1α and IL1β signaling. It also stimulates the immune system to destroy tumour cells. It can be used in treatment of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC). MW :143.56 KD.

Supplier	Selleck Chemicals
Product #	A2444
Sku #	A2444-1mg*5
Pricing	1mg*5, $970.00

Feedback